Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Taber

Showing results (81-90 of 209) with videos related to

Pageof 21
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 3, 2023
The measure of impact: Proposal of quality metrics for solid organ transplant pharmacy practiceMary Moss Chandran, Elizabeth Cohen, Christina Teeter Doligalski, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|August 7, 2016
Concern for Lost Income Following Donation Deters Some Patients From Talking to Potential Living DonorsJames R Rodrigue, Jesse D Schold, Didier A Mandelbrot, et al.
Ethnicity & Disease|March 28, 2013
The impact of diabetes on ethnic disparities seen in kidney transplantationDavid J Taber, Holly B Meadows, Nicole A Pilch, et al.
Pharmacotherapy|November 21, 2012
Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomesDavid J Taber, Nicole A Pilch, Charles F Bratton, et al.
American Journal of Surgery|June 23, 2021
The impact of race on metabolic, graft, and patient outcomes after pancreas transplantationHaley M Gonzales, David J Taber, Satish Nadig, et al.
JMIR Research Protocols|October 2, 2019
Improving Transplant Medication Safety Through a Technology and Pharmacist Intervention (ISTEP): Protocol for a Cluster Randomized Controlled TrialCasey L Hall, Cory E Fominaya, Mulugeta Gebregziabher, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 28, 2009
The use of drotrecogin alfa (activated) in solid organ transplant patients: a case seriesS Berkman, N A Weimert, D J Taber, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 1, 2024
Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantationKarim Soliman, Isabel K Calimlim, Amy Perry, et al.
Clinical Transplantation|August 18, 2019
Long-standing diabetes mellitus and pancreas transplantation: An avenue to increase utilization of an ideal treatment modalityVinayak S Rohan, John W McGillicuddy, David J Taber, et al.
Journal of the American Pharmacists Association : Japha|February 9, 2020
The effect of targeted insurer-mandated prescription monitoring on opioid prescribing patternsJames N Fleming, Jingwen Zhang, David J Taber, et al.
Pageof 21

Showing results (81-90 of 209) with videos related to

Sort By:
Pageof 21
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 3, 2023
The measure of impact: Proposal of quality metrics for solid organ transplant pharmacy practiceMary Moss Chandran, Elizabeth Cohen, Christina Teeter Doligalski, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|August 7, 2016
Concern for Lost Income Following Donation Deters Some Patients From Talking to Potential Living DonorsJames R Rodrigue, Jesse D Schold, Didier A Mandelbrot, et al.
Ethnicity & Disease|March 28, 2013
The impact of diabetes on ethnic disparities seen in kidney transplantationDavid J Taber, Holly B Meadows, Nicole A Pilch, et al.
Pharmacotherapy|November 21, 2012
Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomesDavid J Taber, Nicole A Pilch, Charles F Bratton, et al.
American Journal of Surgery|June 23, 2021
The impact of race on metabolic, graft, and patient outcomes after pancreas transplantationHaley M Gonzales, David J Taber, Satish Nadig, et al.
JMIR Research Protocols|October 2, 2019
Improving Transplant Medication Safety Through a Technology and Pharmacist Intervention (ISTEP): Protocol for a Cluster Randomized Controlled TrialCasey L Hall, Cory E Fominaya, Mulugeta Gebregziabher, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 28, 2009
The use of drotrecogin alfa (activated) in solid organ transplant patients: a case seriesS Berkman, N A Weimert, D J Taber, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 1, 2024
Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantationKarim Soliman, Isabel K Calimlim, Amy Perry, et al.
Clinical Transplantation|August 18, 2019
Long-standing diabetes mellitus and pancreas transplantation: An avenue to increase utilization of an ideal treatment modalityVinayak S Rohan, John W McGillicuddy, David J Taber, et al.
Journal of the American Pharmacists Association : Japha|February 9, 2020
The effect of targeted insurer-mandated prescription monitoring on opioid prescribing patternsJames N Fleming, Jingwen Zhang, David J Taber, et al.
Pageof 21